Key result
Transcatheter aortic valve implantation (TAVI) appears to significantly improve health-related quality of life measures compared with optimal standard care in elderly patients with severe aortic stenosis.
Why the study?
Does Transcatheter aortic valve implantation (TAVI) improve Health-related quality of life (HRQoL) in elderly patients with severe aortic stenosis and high-surgical risk compared with optimal standard care?
Does Transcatheter aortic valve implantation (TAVI) improve Health-related quality of life (HRQoL) in elderly patients with severe aortic stenosis and high-surgical risk compared with optimal standard care?
Answers are grounded in this paper and cite their sources.
TAVI significantly improves health-related quality of life in elderly, high-risk patients with severe aortic stenosis, restoring it to age-adjusted population norms.
Transcatheter aortic valve implantation (TAVI) is a tremendous therapeutic advance for patients with severe aortic stenosis and high-surgical risk. Since TAVI-treated patients are elderly with multiple co-existing conditions, limited life expectancy and disproportionate health-care expenditures, the aspect of the health-related quality of life (HRQoL) benefits becomes of fundamental importance. Based on recent evidence, TAVI appears to improve significantly HRQoL measures compared with optimal standard care, which are restored to age-adjusted population norms over time.
No takes yet. Share an insight, caveat, or question.
Γεωργιάδου et al. (2012) conducted a review in severe aortic stenosis and high-surgical risk. Transcatheter aortic valve implantation (TAVI) vs. optimal standard care was evaluated on health-related quality of life (HRQoL). Transcatheter aortic valve implantation (TAVI) appears to significantly improve health-related quality of life measures compared with optimal standard care in elderly patients with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: